Skip to main content
SpringerLink
Log in

Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases

  • Clinical Immunopathology
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ablashi DV, Allal L, Armstrong G, Bouguermouh A, Pearson GR, Levine PH, Bengali Z, Easton JM, Zaghouani S, Chouiter A, Allouache A, Ghouadni R (1981) Some characteristics of nasopharyngeal carcinoma in Algeria. In: Grundman E, Krueger GRF, Ablashi DV (eds) Cancer campaign, vol 5. Gustav Fischer Verlag, Stuttgart New York, pp 167–175.

    Google Scholar 

  2. Andiman WA, Eastman R, Martin K, Katz BZ, Rubinstein A, Pitt J, Pahwa S, Miller G (1985) Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet II: 1390.

    Google Scholar 

  3. Angel G, Decaussin J, Daillie J, Ooka T (1987) Comparison of early polypeptides induced in EBV producer and non-producer lymphoid cell lines. Ann Inst Pasteur 138: 169.

    Google Scholar 

  4. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B95–8 Epstein-Barr virus genome. Nature 310: 207.

    Google Scholar 

  5. Bernheim A, Berger R, Lenoir G (1981) Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8; 14), t(2; 8) and t(8; 22) translocations. Cancer Genet Cytogenet 3: 307.

    Google Scholar 

  6. Burkitt DP (1970) Geographical distribution. In: Burkitt DP, Wright DH (eds) Burkitt's lymphoma. Livingstone, Edinburgh London, pp 186–197.

    Google Scholar 

  7. Chen JY, Liu MY, Chen CJ, Hsu MM, Tu SM, Lee SH, Kuo SL, Yang CS (1985) Antibody to Epstein-Barr virus specific DNase as a marker for the early detection of nasopharyngeal carcinoma. J Med Virol 17: 47.

    Google Scholar 

  8. Chen JY, Chen CJ, Liu MY, Cho SM, Hsu MM, Lynn TC, Shieh T, Tu SM, Lee HH, Kuo SL, Lai MY, Hsieh CY, Hu CP, Yang CS (1987) Antibodies to Epstein-Barr virus specific DNase in patients with nasopharyngeal carcinoma and control groups. J Med Virol 23: 11.

    Google Scholar 

  9. Chen JY, Chen CJ, Liu MY, Cho SM, Hsu MM, Lynn TC, Shieh T, Tu SM, Beasley RP, Hwang LY, Lee HH, Kuo SL, Yang CS (1989) Antibody to Epstein-Barr virus specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J Med Virol 27: 269.

    Google Scholar 

  10. Cheng YC, Chen JY, Glaser R, Henle W (1980) Frequency and levels of antibodies to Epstein-Barr virus specific DNase are elevated in patients with nasopharyngeal carcinoma. Proc Natl Acad Sci USA 77: 6162.

    Google Scholar 

  11. Desgranges C, De Thé G (1987) IgA and nasopharyngeal carcinoma. In: De Thé G, Ito Y, Rapp F (eds) Oncogenesis and herpesviruses III. IARC Scientific Publication, Lyon, pp 883–891.

    Google Scholar 

  12. De Thé G (1982) Epidemiology of Epstein-Barr virus and associated diseases in man. In: Roizman B (ed) The herpesvirus. Plenum Press, New York, p 25.

    Google Scholar 

  13. De Thé G, Lenoir G (1977) Comparative diagnosis of Epstein-Barr virus related diseases: infectious mononucleosis. Burkitt's lymphoma and nasopharyngeal carcinoma. In: Kurstak E (ed) Comparative diagnosis of viral diseases. Academic Press, New York, pp 196–241.

    Google Scholar 

  14. De Thé G, Zeng Y (1986) Population screening for EBV markers: toward improvement of nasopharyngeal carcinoma control. In: Epstein MA, Achong BG (eds) the Epstein-Barr virus: recent advances. William Heinemann Medical Books, London, pp 237–249.

    Google Scholar 

  15. De Thé G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bornkamm GW, Feorino P, Henle W (1978) Epidemiological evidence fo a causal relationship between Epstein-Barr virus and Burkitt's lymphoma: results of the Ugandan prospective study. Nature 274: 756.

    Google Scholar 

  16. De Thé G, Lavoué MF, Muenz L (1987) Differences in EBV antibody titers of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. In: De Thé G, Ito Y (eds) Nasopharyngeal carcinoma: ethnology and control. IARC, Lyon, pp 471–481.

    Google Scholar 

  17. De Turenne-Tessier M, Ooka T, De Thé G, Daillie J (1986) Characterization of an Epstein-Barr virus-induced thymidine kinase. J Virol 57: 1105.

    Google Scholar 

  18. De Vathaire F, Sancho-Garnier H, Pieddeloup C, Schwaab G, Ho JHC, Ellouze R, Micheau C, Cammoun M, Cachin Y, De Thé G (1988) Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study. Int J Cancer 42: 176.

    Google Scholar 

  19. Dillner J, Szigeti R, Henle W, Henle G, Lerner R, Klein G (1987) Cellular and humoral immune responses to synthetic peptides deduced from the amino acid sequences of Epstein-Barr virus-encoded proteins in EBV-transformed cells. Int J Cancer 40: 455.

    Google Scholar 

  20. Dölken G, Hecht T, Röckel D, Hirsch FW (1987) Characterization of the Epstein-Barr virusinduced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody and human antibodies. Virology 157: 460.

    Google Scholar 

  21. Ellouz R, Cammoun M, Ben-Altia R, Bahi J (1978) NPC in children and adolescents in Tunisia: clinical aspects and paraneoplastic syndrome. In: De Thé G, Ito Y (eds) Etiology and control. IARC, Lyon, pp 115–129.

    Google Scholar 

  22. Emini EA, Luka J, Armstrong ME, Keller PM, Ellis RW, Pearson GR (1987) Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to varicella-zoster glycoprotein II and herpes simplex virus glycoprotein B. Virology 157: 552.

    Google Scholar 

  23. Evans AS, Niederman JC (1976) Epstein-Barr virus. In: Evans AS (ed) Viral infections of humans: epidemiology and control. Plenum Press, New York, pp 209–234.

    Google Scholar 

  24. Fox RI, Pearson G, Vaughan JH (1986) Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol 137: 3162.

    Google Scholar 

  25. Fox RI, Scott S, Houghten R, Whalley A, Geltofsky J, Vaughan J, Smith R (1987) Synthetic peptide derived from the Epstein-Barr virus encoded early diffused antigen (EA-D) reactive with human antibodies. J Clin Lab Anal 1: 140.

    Google Scholar 

  26. Gerber P, Walsh JN, Purcell RH (1969) Association of EB-virus infection with the post-perfusion syndrome. Lancet I: 593.

    Google Scholar 

  27. Gerber P, Goldstein LL, Lucas S, Nonoyama M, Perlin E (1972) Oral excretion of Epstein-Barr viruses by healthy subjects and patients with infectious mononucleosis Lancet II: 988.

    Google Scholar 

  28. Ginsburg M (1990) Antibodies against the large subunit of the Epstein-Barr virus-encoded ribonucleotide reductase in patients with nasopharyngeal carcinoma. Int J Cancer 45: 1048.

    Google Scholar 

  29. Gong M, Ooka T, Matsuo T, Kieff E (1987) Epstein-Barr virus glycoprotein homologous to Herpes simplex virus gB. J Virol 61: 499.

    Google Scholar 

  30. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, Freese UK (1985) Replication of Epstein-Barr virus within the epithelial cells of oral “Hairy” leucoplakia, an AIDS-associated lesion. N Engl J Med 313: 1564.

    Google Scholar 

  31. Halili MR, Spigland I, Foster N, Ghossein NA (1978) Epstein-Barr virus (EBV) antibody in patients treated by radiotherapy for head and Neck cancer. J Surg Oncol 10: 457.

    Google Scholar 

  32. Henderson BE, Louie E, Bogdanoff E, etal (1974) Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers. Cancer Res 34: 1207.

    Google Scholar 

  33. Henderson BE, Louie E, Jing JS, Buell P, Gardner MB (1976) Risk factors associated with nasopharyngeal carcinoma. N Engl J Med 295: 1101.

    Google Scholar 

  34. Henle G, Henle W, Klein G, Gunren P, Clifford P, Morrow R, Ziegler J (1971) Antibodies to early Epstein-Barr virus induced antigens in Burkitt's lymphoma. J Natl Cancer Inst 46: 861.

    Google Scholar 

  35. Henle W, Henle G, Harrison FS, Joyner CR, Klemola E, Paloheimo J, Scriba M, Von Essen F (1968) Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery. N Engl J Med 282: 1068.

    Google Scholar 

  36. Henle W, Henle G, Zajac BA, Pearson G, Waubke R, Scriba M (1970) Differencial reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 169: 188.

    Google Scholar 

  37. Henle W, Henle G, Anderson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE (1987) Antibody response to Epstein-Barr virus-determined antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 84: 570.

    Google Scholar 

  38. Ho JHC (1970) The natural history and treatment of nasopharyngeal carcinoma (NPC). In: Lee Clark R, Cumley R, McCay JE, Copeland M (eds) Oncology, vol 4. Medical Publishers, Year Book, Chicago, pp 1–14.

    Google Scholar 

  39. Ho M, Miller G, Atchison RW, Breining MK, Dummer JS, Andiman W, Starzl TE, Eastman R, Griffith BP, Hardesty RL, Bahnson HT, Hakala TR, Rosenthal JT (1985) Epstein-Barr virus infection and DNA hybridization studies in post-transplantation lymphoma and lymphoproliferate lesions: the role of primary infection. J Infect Dis 152: 876.

    Google Scholar 

  40. Hsu MM, Chen JY, Chen CJ, Hsieh T, Lynn TC (1986) Dynamics of the antibody titers to Epstein-Barr virus specific DNase and viral capsid antigen in IgA class in the course of patients with nasopharyngeal carcinoma. In: Levine PH, Ablashi DV, Nonoyama M, Pearson GR, Glaser R (eds) Epstein-Barr virus and Human diseases. Humana Press, Clifton, pp 13–17.

    Google Scholar 

  41. Huang DP, Chan KM, Tsao SY, Ho YH, McGuire LJ, Ng HK, Lee GCK (1988) EBV associated head and neck tumours and thymic lesions. In: Ablashi DV, Faggioni A, Krueger GRF, Pagano JS, Pearson GR (eds) Epstein-Barr virus and Human diseases. Humana Press, Clifton, pp 277–280.

    Google Scholar 

  42. Johansson B, Klein G, Henle W, Henle G (1970) Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. Int J Cancer 6: 450.

    Google Scholar 

  43. Jondal M (1976) Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virusdetermined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. Clin Exp Immunol 25: 1.

    Google Scholar 

  44. Jones JF, Straus SE (1987) Chronic Epstein-Barr virus infection. Annu Rev Med 38: 195.

    Google Scholar 

  45. Kahan A, Amor B, Menkes CJ (1985) Different defects of T-cell regulation of Epstein-Barr virusinduced B-cell activation in rheumatoid arthritis. Arthritis Rheum 28: 961.

    Google Scholar 

  46. Kallin B, Luka J, Klein G (1979) Immunochemical characterization of Epstein-Barr virus (EBV) associated early and late antigens in n-butyrate-treated P3HR1 cells. J Virol 32: 710.

    Google Scholar 

  47. Kawanishi M, Sugawara K, Ito Y (1981) Epstein-Barr virus-induced polypeptides: a comparative study with superinfected Raji, IUdR-treated and n-butyrate-treated P3HR1 cells. Virology 109: 72.

    Google Scholar 

  48. Kieff E, Leibowitz D (1990) Epstein-Barr virus and its replication In: Fields BN, Knipe DM et al (eds) Virology, 2nd edn. Raven Press, New York, pp 1889–1920.

    Google Scholar 

  49. Klein G (1973) The Epstein-Barr Virus. In: Kaplan AS (ed) The herpesviruses. Academic Press, New York, p 521.

    Google Scholar 

  50. Levine PH, Ablashi DV, Berard CW, Carbon PP, Waggoner DE, Malan L (1971) Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer 27: 416.

    Google Scholar 

  51. Littler E, Zeuthen J, McBride AA, Sorensen ET, Powell KL, Walsh-Arrand JE, Arrand J (1986) Identification of an Epstein-Barr virus coded thymidine kinase. EMBO J 5: 1959.

    Google Scholar 

  52. Littler E, Newman W, Arrand JR (1990) Immunological response of nasopharyngeal carcinoma patients to the Epstein-Barr virus-coded thymidine kinase expressed in E. coli. Int J Cancer 45: 1028.

    Google Scholar 

  53. Liu MY, Cou WM, Nutter L, Hsu MM, Chen JY (1989) Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma. J Med Virol 28: 101.

    Google Scholar 

  54. Luka J, Miller G, Jornvall H, Pearson GR (1986) Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein. J Virol 58: 748.

    Google Scholar 

  55. Manolov G, Manolova Y (1972) Marker bank in one chromosome 14 from Burkitt's lymphomas. Nature 237: 33.

    Google Scholar 

  56. Middeldorp JM, Herbrink P (1988) Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. J Virol Methods 21: 133.

    Google Scholar 

  57. Miller G, Beebe GW (1973) Infectious mononucleosis and the empirical risk of cancer. J Natl Cancer Inst 50: 315.

    Google Scholar 

  58. Mueller M, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich NO, Polk BF, Vogelman J (1989) Hodgkin's disease and Epstein-Barr virus: altered antibody pattern before diagnosis. N Engl J Med 320: 689.

    Google Scholar 

  59. Muir CS (1972) Nasopharyngeal carcinoma in non-Chinese populations. In: Biggs PM, De Thé Payne LN (eds) Oncogenesis and herpesviruses. IARC, Lyon, pp 367–371.

    Google Scholar 

  60. Ooka T (1985) The molecular biology of Epstein-Barr virus. Biomed Pharmacother 39: 59.

    Google Scholar 

  61. Ooka T, Calander A, De Turenne M, Daillie J (1983) Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity. J Virol 46: 187.

    Google Scholar 

  62. Ooka T, De Turenne M, De Thé G, Daillie J (1984) Epstein-Barr virus-specific DNase activity in nonproducer Raji cells after treatment with 12–0-tetradecanoylphorbol-13-acetate and sodium butyrate. J Virol 49: 626.

    Google Scholar 

  63. Ooka T, Lenoir GM, Decaussin G, Bornkamm GW, Daillie J (1986) Epstein-Barr virus specific DNA polymerase in virus nonproducer Raji cells. J Virol 58: 671.

    Google Scholar 

  64. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320.

    Google Scholar 

  65. Pearson GR, Luka J (1986) Characterization of Epstein-Barr virus-determined antigens. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus: recent advances. William Heinemann Medical Books, London, pp 48–73.

    Google Scholar 

  66. Pearson GR, Johansson B, Klein G (1978) Antibody-dependent cellular cytotoxicity against Epstein-Barr virus associated antigens in African patients with nasopharyngeal carcinoma. Int J Cancer 22: 120.

    Google Scholar 

  67. Pearson GR, Luka J, Docherty J (1986) Monoclonal antibodies in the diagnosis of EBV-induced disease. In: Lopez C, Roizman B (eds) Human herpesvirus infections: pathogenesis, diagnosis and treatment. Raven Press, New York, pp 211–220.

    Google Scholar 

  68. Pearson GR, Luka J, Petti L, Sample J, Birkenback M, Braun D, Kieff E (1987) Identification of an Epstein-Barr virus gene encoding for a second component of the restricted early antigen complex. Virology 160: 151.

    Google Scholar 

  69. Purtilo DT, Tatsumi E, Manolov G, Manolova Y, Harada S, Lipscomb H, Krueger GRF (1985) Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. Int Rev Exp Pathol 27: 113.

    Google Scholar 

  70. Ragni MV, Urbach AH, Kiernan S, Stambouli J, Cohen B, Rabin BS, Winkelstein A, Gartner JC, Zitelli BZ, Malatack JJ, Bontempo FA, Spero JA, Lewis JH (1985) Acquired immunodefficiency syndrome in the child of a haemophiliac. Lancet I: 133.

    Google Scholar 

  71. Rinaldo CR, Kingsley LA, Lyter DW, Rabin BS, Atchison RW, Bodner AJ, Weiss SH, Saxinger WC (1986) Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men. J Infect Dis 154: 556.

    Google Scholar 

  72. Rowe M, Rowe DT, Gregory CD, etal (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6: 2743.

    Google Scholar 

  73. Rowe M, Finke J, Szigeti R, Klein G (1988) Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus. J Gen Virol 69: 1217.

    Google Scholar 

  74. Sculley TB, Pope JH, Hazelton RA (1986) Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis. Arthritis Rheum 29: 964.

    Google Scholar 

  75. Seigneurin JM, Lavoue MF, Genoulaz O, Bornkamm G, Lenoir G (1987) Antibody response against the Epstein-Barr virus-encoded nuclear antigen 2 (EBNA2) in different groups of individuals. Int J Cancer 40: 349.

    Google Scholar 

  76. Stolzenberg MC, Ooka T (1990) Purification and properties of Epstein-Barr virus DNase expressed in Escherichia coli. J Virol 64: 96.

    Google Scholar 

  77. Suyama CV, Boswell RN, Ench Y, Kisner DL, Hersh EM, Reuben JM, Mansell PWA (1986) Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex. J Infect Dis 154: 864.

    Google Scholar 

  78. Tan RS, Cheng YC, Naegele RF, Henle W, Glaser R, Champion J (1982) Antibody responses to Epstein-Barr virus specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma. Int J Cancer 30: 561.

    Google Scholar 

  79. Tessier M, Ooka T, Calander A, de Thé G, Daillie J (1989) Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus-specific thymidine kinase. Int J Cancer 43: 45.

    Google Scholar 

  80. Tosato G, Straus S, Henle W, Pike SE, Blaese RM (1985) Characteristic T-cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 134: 3082.

    Google Scholar 

  81. Uen WC, Luka J, Pearson GR (1988). Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus. Int J Cancer 41: 479.

    Google Scholar 

  82. Walf H, Motz M, Kühbede R, Jigl W, Fan J, Pi GH, Zeng Y (1987) Development of a set of EBV-specific antigens with recombinant gene technology for diagnosis of EBV-related malignant diseases. In: Levine PH, Ablashi DV, Nonoyama M, Pearson GR, Glaser R (eds) Epstein-Barr virus and Human diseases. Humana Press, Clifton, pp 179–182.

    Google Scholar 

  83. Weiss LM, Movabhed LA, Warnke RA, Skalar J (1989) Detection of Epstein-Barr viral genome in Reed-Steinberg cells of Hodgkin's diseases. N Engl J Med 320: 502.

    Google Scholar 

  84. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB (1988) Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69: 1051.

    Google Scholar 

  85. Zeng Y (1985) Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res 44: 121.

    Google Scholar 

  86. Zeng Y, Wolf H, Takada K, Arrand JR, De Thé G (1988) Detection of EBV specific IgA antibodies to EA, MA and EBNA-1 recombinant proteins in NPC patients and controls. In: Ablashi DV, Faggioni A, Krueger GRF, Pagano JS, Pearson GR (eds) Epstein-Barr virus and human diseases. Humana Press, Clifton, pp 309–313.

    Google Scholar 

  87. Zhang CX, Decaussin G, De Turenne-Tessier M, Daillie J, Ooka T (1987) Identification of an Epstein-Barr virus-specific desoxyribonuclease gene using complementary DNA. Nucleic Acids Res 15: 2707.

    Google Scholar 

  88. Zhang CX, Decaussin G, Daillie J, Ooka T (1988) Altered expression of two Epstein-Barr virus early genes localized in BamH1-A in nonproducer Raji cells. J Virol 62: 1862.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Virologie Moléculaire, UMR30, IVMC, Faculté de Médecine Alexis Carrel, F-69372, Lyon, Cedex, France

    Tadamasa Ooka, Mireille de Turenne-Tessier & Marie Claude Stolzenberg

Authors
  1. Tadamasa Ooka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mireille de Turenne-Tessier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marie Claude Stolzenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ooka, T., de Turenne-Tessier, M. & Stolzenberg, M.C. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases. Springer Semin Immunopathol 13, 233–247 (1991). https://doi.org/10.1007/BF00201471

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00201471

Keywords

Search

Navigation